ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

ACS Journal Cancer Refers I-ELCAP Studies to Office of Human Research Protections

January 6, 2012

Medicine Branch In Quick Recovery Under Meyers After Big Turnover

August 26, 1988

Senate Approves FY08 Labor-HHS Appropriations.

October 26, 2007

In Brief: Barry Pierce New DCCP Chairman; Adamson Seeks Ads For Chemical, Biological Carcinogenesis

June 17, 1983

NCI Awards 12 Grants For Planning of New Cancer Centers

March 27, 1992

In Brief: Salmon, Fidler Head ASCO, AACR; Durant, Pardee Presidents Elect; Namovicz, Other AOs Promoted

May 25, 1984